CNBX Pharmaceuticals Inc. Quarterly Current Ratio in % from Q2 2015 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
CNBX Pharmaceuticals Inc. quarterly Current Ratio history and growth rate from Q2 2015 to Q2 2024.
  • CNBX Pharmaceuticals Inc. Current Ratio for the quarter ending May 31, 2024 was 6.16 %, a 17.9% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 6.16 -1.34 -17.9% May 31, 2024
Q1 2024 8.8 +2.16 +32.5% Feb 29, 2024
Q4 2023 8.29 -2.1 -20.2% Nov 30, 2023
Q3 2023 7.7 -15.1 -66.2% Aug 31, 2023
Q2 2023 7.5 -40.1 -84.2% May 31, 2023
Q1 2023 6.64 -77.8 -92.1% Feb 28, 2023
Q4 2022 10.4 -104 -90.9% Nov 30, 2022
Q3 2022 22.8 -105 -82.1% Aug 31, 2022
Q2 2022 47.6 -90.8 -65.6% May 31, 2022
Q1 2022 84.4 -89.9 -51.6% Feb 28, 2022
Q4 2021 114 -182 -61.4% Nov 30, 2021
Q3 2021 128 -323 -71.7% Aug 31, 2021
Q2 2021 138 -512 -78.7% May 31, 2021
Q1 2021 174 -673 -79.4% Feb 28, 2021
Q4 2020 296 -786 -72.6% Nov 30, 2020
Q3 2020 451 -899 -66.6% Aug 31, 2020
Q2 2020 650 -472 -42.1% May 31, 2020
Q1 2020 847 -78 -8.43% Feb 29, 2020
Q4 2019 1.08K +355 +48.9% Nov 30, 2019
Q3 2019 1.35K +896 +198% Aug 31, 2019
Q2 2019 1.12K +619 +123% May 31, 2019
Q1 2019 925 +391 +73.3% Feb 28, 2019
Q4 2018 726 +340 +87.8% Nov 30, 2018
Q3 2018 453 +151 +50% Aug 31, 2018
Q2 2018 504 +323 +179% May 31, 2018
Q1 2018 534 +490 +1130% Feb 28, 2018
Q4 2017 387 +363 +1507% Nov 30, 2017
Q3 2017 302 +290 +2446% Aug 31, 2017
Q2 2017 181 +168 +1272% May 31, 2017
Q1 2017 43.4 +32.2 +287% Feb 28, 2017
Q4 2016 24.1 +12.2 +102% Nov 30, 2016
Q3 2016 11.9 -13.3 -52.9% Aug 31, 2016
Q2 2016 13.2 -46 -77.7% May 31, 2016
Q1 2016 11.2 Feb 29, 2016
Q4 2015 11.9 Nov 30, 2015
Q3 2015 25.2 Aug 31, 2015
Q2 2015 59.2 May 31, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.